Related Experiment Video

Updated: Aug 31, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Cardiomyocyte apoptosis in hypertensive cardiomyopathy

Arantxa González1, María A Fortuño, Ramón Querejeta

  • 1Division of Cardiovascular Pathophysiology, Centre for Applied Medical Research, School of Medicine, University of Navarra, Pamplona, Spain.

Cardiovascular Research
|September 23, 2003
PubMed

Insights

Cardiomyocyte apoptosis, a form of programmed cell death, is increasingly recognized in hypertensive cardiomyopathy. This review explores evidence of its abnormal stimulation and detrimental impact on cardiac function in hypertension.

Area of Science:

  • Cardiovascular Research
  • Cell Biology
  • Pathophysiology

Background:

  • Traditionally, necrosis was considered the primary cardiomyocyte death mechanism in cardiac diseases.
  • Recent findings indicate cardiomyocyte apoptosis occurs in various conditions, contributing to cell loss and dysfunction.
  • Cardiomyocyte apoptosis is a potential factor in the clinical progression of hypertensive cardiomyopathy.

Purpose of the Study:

  • To review evidence linking cardiomyocyte apoptosis to arterial hypertension.
  • To discuss potential mechanisms driving apoptosis in hypertensive hearts.
  • To explore the impact of cardiomyocyte apoptosis on cardiac function and potential therapeutic strategies.

Main Methods:

  • Review of recent scientific literature and evidence.
  • Analysis of studies on animal models and human subjects with hypertension.
  • Examination of molecular and cellular mechanisms involved in apoptosis.

Main Results:

  • Abnormal stimulation of cardiomyocyte apoptosis is observed in the hearts of hypertensive animals and humans.
  • Cardiomyocyte apoptosis contributes to cardiac dysfunction and adverse outcomes in hypertension.
  • Evidence suggests apoptosis plays a significant role in hypertensive cardiomyopathy.

Conclusions:

  • Cardiomyocyte apoptosis is an important, though not fully proven, factor in hypertensive cardiomyopathy.
  • Understanding the mechanisms of apoptosis in hypertension is crucial for developing targeted therapies.
  • Future strategies may focus on detecting and modulating cardiomyocyte apoptosis to improve outcomes.

More Related Videos

Isolation and Physiological Analysis of Mouse Cardiomyocytes11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...